Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International
Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines
Nicoletta Dentico, Policy and Advocacy Advisor, DNDi
Tuesday, 05 June 2007
An pdf version of this document is available here.
David Serafino[1]
Knowledge Ecology International
4 June 2007
Table of Contents
Saturday, 02 June 2007
The Essential Medical Inventions Licensing Agency
Working Plan, June 1, 2007
Introduction
Sunday, 03 June 2007
IGWG Briefing Paper on Patent Pools
Collective Management of Intellectual Property — The use of Patent Pools to expand access to essential medical technologies
KEI Research Note 2007:3 (1)
Sep 2, 2009 The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed… Continue Reading
KEI is hosting a brownbag lunch to discuss the scope of patentable subject matter with reference to the Supreme Court's forthcoming decision on Bilski's appeal.
Sunday, 29 April 2007
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
Wednesday, 29 August 2007
According to the Novartis strategic alliances webpage, the company is engaged in "More than 400 collaborations in over 20 countries, over 120 collaborations with major biotech companies, and over 280 collaborations with academic centers."
Novartis and Bayer Schering AG – PTK/ZK – These two companies initially collaborated in the devel Continue Reading
Thursday, 06 September 2007
Friday, 07 September 2007
According to the Merck licensing and partnership website, "Eleven of our 20 new products launched since 1995 are the result of licensing alliances." The site lists Merck's partners, which include small and medium-sized pharma, universities, and biotech firms, but none of their big pharma competitors.